Please assess the completion status of the following clinical trial:

Trial Title: Saccadic Reaction Time and Preterm Pre-eclampsia

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria for cases:~1. Age ≥ 18 years~2. Confirmed diagnosis of pre-eclampsia, as defined by the International Society for the Study of Hypertension in Pregnancy (ISSHP)~3. Gestational age \< 35+0 weeks~4. Participant is willing and able to give informed consent~Inclusion criteria for controls:~1. Age ≥ 18 years~2. Absence of essential hypertension and pre-eclampsia or pregnancy-induced hypertension in current and previous pregnancies~3. Gestational age \< 35+0 weeks~4. Participant is willing and able to give informed consent~Exclusion Criteria:~1. Maternal neurological or psychiatric disorder (e.g. epilepsy, migraine, multiple sclerosis, depression, etc.)~2. Use of medication (other than vitamin supplements \[cases and controls\] and those for treatment or prevention of pre-eclampsia \[cases\]) during pregnancy

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Preterm pre-eclampsia (cases) (Type: None): Pregnant patients diagnosed with pre-eclampsia prior to 35 weeks gestation
- Pregnant patients (controls) (Type: None): Age- and gestation-matched pregnant patients who are not suffering with pre-eclampsia, hypertensive disease or any other neuropsychiatric condition

Based on this trial design, predict the completion outcome and termination type (if applicable).